Repros Therapeutics Inc (RPRX)

[y3maxx]

"""iii) should report 2nd round of open label fibroid efficacy data here by end of month- safety already reported per PR last week. no d+cs or safety ises. should have 3rd round of open label done by summer with results shortly thereafter."""

,,,hmmmm,,,Efficacy, open round,,,,followed with an IND approval,,,what's left to prevent a partnership,,,besides terms?

Y3maxx can see the ducks being lined up,,,it is interesting the board naysayers or the 1 million short position can't see it.

,,,good luck

OT: have taken a small position in CAMH,,,first important date is March 22nd.